DNA icon

Autosomal Recessive Cutis Laxa Type IIA (ARCL2A) and Wrinkly Skin Syndrome (WSS) via the ATP6V0A2 Gene

Summary and Pricing

Test Method

Sequencing and CNV Detection via NextGen Sequencing using PG-Select Capture Probes
Test Code Test Copy GenesTest CPT Code Gene CPT Codes Copy CPT Codes Base Price
ATP6V0A2 81479 81479,81479 $990
Test Code Test Copy Genes Test CPT Code Gene CPT Codes Copy CPT Code Base Price
8031ATP6V0A281479 81479,81479 $990 Order Options and Pricing

Pricing Comments

Testing run on PG-select capture probes includes CNV analysis for the gene(s) on the panel but does not permit the optional add on of exome-wide CNV analysis. Any of the NGS platforms allow reflex to other clinically relevant genes, up to whole exome or whole genome sequencing depending upon the base platform selected for the initial test.

An additional 25% charge will be applied to STAT orders. STAT orders are prioritized throughout the testing process.

This test is also offered via a custom panel (click here) on our exome or genome backbone which permits the optional add on of exome-wide CNV or genome-wide SV analysis.

Turnaround Time

3 weeks on average for standard orders or 2 weeks on average for STAT orders.

Please note: Once the testing process begins, an Estimated Report Date (ERD) range will be displayed in the portal. This is the most accurate prediction of when your report will be complete and may differ from the average TAT published on our website. About 85% of our tests will be reported within or before the ERD range. We will notify you of significant delays or holds which will impact the ERD. Learn more about turnaround times here.

Targeted Testing

For ordering sequencing of targeted known variants, go to our Targeted Variants page.


Genetic Counselors


  • Stela Berisha, PhD, FACMG

Clinical Features and Genetics

Clinical Features

Autosomal recessive cutis laxa type IIA (ARCL2A, also referred as Derby type; OMIM 219200) is characterized by hypotonia, over-folded skin, dysmorphic facial features at birth, development delay, and mental retardation. Other common manifestations include enlarged anterior fontanelle, congenital hip dislocation, high myopia, strabismus, and seizures caused by malformation of cortical and cerebella tissues. The dysmorphic features and abnormal neurological symptoms become severe over time, and some patients may lose the ability to walk by adolescence. However, the skin conditions may improve over time. A few patients have abnormalities in the cardiovascular, urogenital, and hematological systems. Wrinkly skin syndrome (WSS; OMIM 278250) is a relatively mild disorder. Patients with the syndrome may have reduced skin elasticity, dental abnormalities (small teeth, delayed eruption, caries), and delayed closure of the fontanel (Hucthagowder et al. Hum Mol Genet 18:2149–2165, 2009; Morava et al. Eur J Hum Genet 17:1099-1110, 2009; Maldergem et al. Genereview, 2011).


ARCL2A and WSS are inherited in an autosomal recessive manner and are caused by variants in ATP6V0A2, which encodes the a2 subunit of the vesicular H+ pump and is a member of the ATPase protein complex family. Variants in ATP6V0A2 impair Golgi vesicle trafficking and prevent the production of functional glycosylation. This results in reduced or abnormal elastic fiber formation. Most known ATP6V0A2 variants are truncating variants, which were found throughout the gene. Missense variants involving proline residues near or within the transmembrane domain are shown to cause ARCL2A (p.P87L, p.P405L, and p.P792R). In addition, a large in-frame deletion (c.1936_2055del, p.E646_685del) was reported in four unrelated patients originating from Iran and Turkey (Hucthagowder et al. Hum Mol Genet 18(12):2149–2165 2009; Morava et al. Eur J Hum Genet 17:1099-1110, 2009; Maldergem et al. GeneReviews, 2011).

Clinical Sensitivity - Sequencing with CNV PG-Select

Two studies reported that the ATP6V0A2 variants were identified in 27 out of the 29 clinically-diagnosed ARCL2A or WSS families/patients screened by transferrin isoelectric focusing (Kornak et al. 2008; Hucthagowder et al. 2009).

Testing Strategy

This test provides full coverage of all coding exons of the ATP6V0A2 gene, plus ~10 bases of flanking noncoding DNA. We define full coverage as >20X NGS reads or Sanger sequencing.

Indications for Test

Individuals with clinical diagnosed ARCLA2 and WSS. Individuals diagnosed by transferrin isoelectric focusing, mass spectrometry, or skin biopsy are preferred. This test may also be considered for the reproductive partners of individuals who carry pathogenic variants in ATP6V0A2.


Official Gene Symbol OMIM ID
ATP6V0A2 611716
Inheritance Abbreviation
Autosomal Dominant AD
Autosomal Recessive AR
X-Linked XL
Mitochondrial MT

Related Tests

Autosomal Recessive Cutis Laxa Type 3A (ARCL3A) via the ALDH18A1 Gene
Cutis Laxa via the PYCR1 Gene
Cutis Laxa, Type 1B (ARCL1B) via the EFEMP2 Gene
Geroderma Osteodysplasticum (GO) via the GORAB Gene
Macrocephaly, Alopecia, Cutis Laxa and Scoliosis (MACS) Syndrome via the RIN2 Gene
Menkes Disease and Hereditary Motor Neuropathy via the ATP7A Gene


  • Hucthagowder et al. Loss-of-function mutations in ATP6V0A2 impair vesicular trafficking, tropoelastin secretion and cell survival. Hum Mol Genet  18(12):2149-2165, 2009. PubMed ID: 19321599
  • Kornak et al. Impaired glycosylation and cutis laxa caused by mutations in the vesicular H+-ATPase subunit ATP6V0A2. Nat Genet. 40:32-34, 2008 PubMed ID: 18157129
  • Maldergem et al. GeneReviews, 2011 PubMed ID: 20301755
  • Morava et al. Autosomal recessive cutis laxa syndrome revisited. Eur J Hum Genet  17:1099-1110, 2009. PubMed ID: 19401719


Ordering Options

We offer several options when ordering sequencing tests. For more information on these options, see our Ordering Instructions page. To view available options, click on the Order Options button within the test description.

myPrevent - Online Ordering

  • The test can be added to your online orders in the Summary and Pricing section.
  • Once the test has been added log in to myPrevent to fill out an online requisition form.
  • PGnome sequencing panels can be ordered via the myPrevent portal only at this time.

Requisition Form

  • A completed requisition form must accompany all specimens.
  • Billing information along with specimen and shipping instructions are within the requisition form.
  • All testing must be ordered by a qualified healthcare provider.

For Requisition Forms, visit our Forms page

If ordering a Duo or Trio test, the proband and all comparator samples are required to initiate testing. If we do not receive all required samples for the test ordered within 21 days, we will convert the order to the most effective testing strategy with the samples available. Prior authorization and/or billing in place may be impacted by a change in test code.

Specimen Types

Specimen Requirements and Shipping Details

loading Loading... ×


An error has occurred while calculating the price. Please try again or contact us for assistance.

View Ordering Instructions

1) Select Test Method (Platform)

1) Select Test Type

2) Select Additional Test Options

No Additional Test Options are available for this test.

Note: acceptable specimen types are whole blood and DNA from whole blood only.
Total Price: loading
Patient Prompt Pay Price: loading
A patient prompt pay discount is available if payment is made by the patient and received prior to the time of reporting.
Show Patient Prompt Pay Price
Copy Text to Clipboard